As of November 2025, according to Mettler Toledo International's current financial statements, the company's 12-month EPS is $39.59. Mettler Toledo International's EPS for 2024 amounted to $40.67, marking an increase from $36.1 in 2023. Mettler Toledo International's earnings per share for the quarterly report ending on Jun 30, 2025 reached $9.78.
The annual EPS for the year 2024 was $40.67, an increase of 12.7% from $36.1 in 2023. The quarterly per-share earnings for the period ending Jun 30, 2025, was $9.78, indicating a 6.1% decrease from the same quarter last year. MTD's 12-month EPS stands at $39.59 as of June 2025. Mettler Toledo International's annual EPS in 2023 stood at $36.1, a 6.9% decrease year-over-year.
During the last 12 months, Mettler Toledo International has seen an EPS growth of -6.1% (YoY, quarterly). Throughout the last three years, the company had an average EPS growth of 6.9% per year. During the last 5 years, the company had an average EPS growth rate of 12.2%. When measured over a ten-year period, MTD's average EPS growth rate was 13.3%.
| Stock name | Price to Earnings | EPS grwoth 1Y | EPS grwoth 3Y | EPS grwoth 5Y |
|---|---|---|---|---|
| TMO Thermo Fisher Scientific Inc | 32.67 | 6.8% | -5.5% | 12.4% |
| WAT Waters Corp | 34.09 | -1.1% | -1.5% | 4.2% |
| MTD Mettler Toledo International Inc | 36.27 | 12.7% | 6.9% | 12.2% |
| XYL Xylem Inc | 38.74 | 30.6% | 15.7% | 10.5% |
| DHR Danaher Corp | 43.49 | -17.2% | -15.3% | 5.3% |
| BRKR Bruker Corp | 77 | -74% | -25.4% | -9.8% |
| BIO Bio-Rad Laboratories Inc | N/A | -199.5% | N/A | N/A |
| HBIO Harvard Bioscience Inc | N/A | -250% | N/A | N/A |
All data is based on quarterly TTM periods, unless otherwise specified.